Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Cisplatin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 39 Lung Neoplasms 24 Squamous Cell Carcinoma of Head and Neck 21 Carcinoma 10 Urinary Bladder Neoplasms 9 Oropharyngeal Neoplasms 8 Neoplasm Metastasis 8 Nasopharyngeal Carcinoma 8 Colorectal Neoplasms 8 Uterine Cervical Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Ovarian Neoplasms 7 Laryngeal Neoplasms 7 Stomach Neoplasms 6 Mouth Neoplasms 6 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Neoplasms 5 Esophageal Neoplasms 5 Mesothelioma, Malignant 4 Hypopharyngeal Neoplasms 4 Gallbladder Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Squamous Cell 4 Biliary Tract Neoplasms 4 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Lymphoid Interstitial Pneumonia 3 Endometrial Neoplasms 3 Colonic Neoplasms 3

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡